4//SEC Filing
WENTWORTH KORY JAMES 4
Accession 0001689375-25-000016
CIK 0001689375other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:32 PM ET
Size
4.9 KB
Accession
0001689375-25-000016
Insider Transaction Report
Form 4
WENTWORTH KORY JAMES
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-03-17$10.67/sh−1,784$19,035→ 109,536 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.
Documents
Issuer
Entrada Therapeutics, Inc.
CIK 0001689375
Entity typeother
Related Parties
1- filerCIK 0001725663
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:32 PM ET
- Size
- 4.9 KB